Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04020406
Other study ID # 2323297
Secondary ID
Status Completed
Phase
First received
Last updated
Start date November 1, 2017
Est. completion date November 1, 2018

Study information

Verified date July 2019
Source Assiut University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Antibacterial properties of urea was tested against 35 isolates from ocular infections.


Description:

In vitro susceptibility testing was performed with commercially available antibiotic discs, homemade urea discs saturated with urea solution at a concentration of 96 mmol. The weight of urea in one drop = 0.37 mg, in one ml = 10.34 mg (5 microliter/ disc) discs and combined discs (antibiotic discs to which urea solution was added). Combined discs provided better in vitro susceptibility results than antibiotics alone.

Scanning electron micrographs of bacterial isolates incubated overnight with urea solution showed marked disruption of bacterial aggregative patterns and irregularities of their cell walls.

Western blotting showed marked reduction in total proteins in bacterial isolates incubated overnight with urea solution. These findings may explain the possible mechanisms for antibacterial activity of urea solution as a result of protein denaturation.


Recruitment information / eligibility

Status Completed
Enrollment 90
Est. completion date November 1, 2018
Est. primary completion date November 1, 2018
Accepts healthy volunteers No
Gender All
Age group 5 Months to 65 Years
Eligibility Inclusion Criteria:

- ocular infection

Exclusion Criteria:

- Local antibiotics treatment

Study Design


Related Conditions & MeSH terms


Intervention

Biological:
Antibacterial Activity
Antibacterial Activity of Urea Solution against Ocular Bacterial Isolates

Locations

Country Name City State
Egypt Hassan Lotfy Fahmy Assiut

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Antibacterial effect of Urea Solution against Ocular Bacterial Samples were both inoculated on Muller Agar (Sigma-Aldrich) plates and directly examined under the microscope using Gram stained smears. Inoculated plates were incubated at 37oC for 48 hrs.
Gram negative isolates were sub-cultured on MacConkey's, Eosin Methelyene Blue (EMB) and Cystine Lactose Electrolyte Deficient (CLED) agar plates (Sigma-Aldrich). Gram positive isolates were sub-cultured on Mannitol Salt agar plates (Sigma-Aldrich).
6 month